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Fluorescent biosensors that facilitate reagentless sensitive 
detection of small molecules are crucial tools in the areas of 
therapeutics and diagnostics.
1-3
 The receptor-based fluorescent 
sensor is a representative case of fluorescent biosensors, in which 
the receptor component that captures the target ligand usually 
sets the sensitivity and selectivity of the sensor and the signal 
transduction component of the sensor is responsible for 
converting the ligand-binding event into measurable fluorescence 
signals.
4-6
 For generating the receptor component, in vitro 
selection, also known as SELEX (systematic evolution of ligands 
by exponential enrichment),
7-9
 offers an effective strategy for 
generating RNA or DNA receptors (aptamers) with appropriate 
affinity and specificity for various targets, for which naturally 
occurring protein receptors are not accessible.
10-13
 Modification 
of RNA and DNA aptamers with the fluorescence reporter 
component affords many RNA- and DNA-based fluorescent 
sensors.
14
 We have reported a modular strategy for tailoring 
fluorescent ribonucleopeptide (RNP) sensors for ATP with a 
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A RNA-derived RNP library, in which the Rev Responsive 
Element (RRE) RNA appended with a randomized nucleotides 
region was complexed with the Rev peptide,
17-18
 was applied for 
in vitro selection to obtain RNP receptors for various targets.
19
 
RNP receptors are converted into target-specific fluorescent 
sensors by modification of the N-terminal of the Rev peptide 
with various kinds of fluorophores.
16, 20-22
 
For the fluorescent RNP sensors to realize the selective 
sensing of small molecules, it is necessary to obtain RNP 
receptors with distinct selectivity to the target ligand. The first 
step of the stepwise molding of fluorescent RNP sensors, namely 
the in vitro selection step, controls the selectivity and affinity of 
the sensor for the target. The way by which the substrate was 
immobilized to the resin is an important parameter to control the 
selectivity and the affinity of RNP receptors.
23-26
 It has also been 
reported that the conditions for the equilibrium binding of the 
library of molecules (RNA or DNA) to the target control the 
affinity and selectivity of aptamers.
27
  
In this report, biologically active catecholamines are chosen as 
the target for the RNP receptor-based fluorescent sensor to ask a 
question of whether the subtle difference in the structure of small 
molecules could be selectively recognized by the RNP receptors 
and/or sensors. Catecholamines have closely related but distinct 
structures of the catechol ring with aliphatic chain, which is the 
key characteristic for each catecholamine to exert a different 
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receptor activation activity. Because dopamine is a valuable 
heuristic bridge in defective brain chemistry study over the past 
medical history,
28 
 it is of particular interest to prepare a suitable 
analytical tool for dopamine that will accelerate clear 
understanding of the relationship between the function and the 
structure
29
 of each biologically active catecholamine. In the 
catecholamine biosynthesis pathway (Figure 1), dopamine is 
produced by the hydroxylation of L-tyrosine followed by the 
decarboxylation of L-dihydoxyphenylalanine (L-dopa) by 
aromatic L-amino acid decarboxylase. Likewise, dopamine is the 
intermediate precursor of norepinephrine and epinephrine. As the 
further response, dopamine is converted to norepinephrine by 
dopamine-β-hydroxylase. Finally, phenylethanolamineN-methyl 
transferase catalyzes conversion of norepinephrine to 
epinephrine.
30
 Each catecholamine has a distinct structure of a 
benzene ring with two hydroxyl groups and a terminal 
aminoethyl group.  
In order to prepare fluorescent sensors specific for dopamine, 
receptors that successfully discriminate dopamine from those 
other catecholamine derivatives, such as norepinephrine and 
epinephrine, are required (Figure 1). Previously, dopamine-
binding RNA aptamers were isolated by in vitro selection
31
 and 
its DNA homologues were reported to retain the dopamine-
binding DNA activity.
32
 The RNA aptamer specifically 
recognized the catechol group bearing 3- and 4-hydroxyl groups, 
but it was relatively insensitive to the modification at the 
aminoethyl moiety. Thus, it is an interesting challenge to design 
an efficient selection scheme to isolate dopamine-binding 
receptors with distinct specificity over L-dopa, norepinephrine 
and epinephrine. We report here dopamine-binding RNP 
receptors obtained by various in vitro selection schemes 
including the counter-selection and construction of fluorescent 
dopamine sensors through the stepwise molding strategy. We 
have also investigated the mechanisms by which RNP receptors 
recognize dopamine and demonstrated that the condition applied 





Figure 1. (a) The biosynthetic pathway for the catecholamine 
neurotransmitters from tyrosine. TH, tyrosine hydroxylase; AAD, aromatic L-
amino acid decarboxylase; DβH, dopamine-β-hydroxylase; PNMT, 
phenylethanolamine methyltransferase. Dopa, 3,4-dihydroxyphenylalanine. 
(b) Structures of ligands bearing catecholamine-related functional groups 




2.1. Design of in vitro selection schemes for obtaining 
dopamine-binding ribonucleopeptides.  
We have combined a negative selection step using tyrosine-
agarose resin at each round of the RNP selection protocol. 
Mannironi et al. selected dopamine-binding RNA aptamers at a 
quite high salt concentration (50 mM Tris-HCl, pH 7.4, 500 mM 
NaCl, and 5 mM MgCl2) that would avoid nonspecific charge 
interactions between RNA and dopamine.
31
 In vitro selection of 
RNP was carried out under two different NaCl concentrations 
150 and 300 mM to check the effect of salt concentrations. 
RNP receptors for dopamine were selected from RNP libraries 
(RRENn RNP library) consisting of various lengths of 
randomized nucleotides, ranging from 7 to 40 nucleotides.
22 
The 
RNP library was incubated with a tyrosine-immobilized agarose 
resin under two different NaCl concentrations as the negative 
selection step. During this step, RNPs that showed affinity to the 
carboxyl group at the α position of the amino group would be 
eliminated. The flow through fraction was subjected to a second 
incubation with a dopamine-immobilized agarose resin at each 
salt condition. Unbound RNP species were extensively washed 
away with each binding buffer. The resin-bound RNA fractions 
eluted by the dopamine-containing buffer (5 mM dopamine) were 
collected, reverse transcribed, and applied to successive RT-PCR 
amplification to generate a new DNA pool. DNA templates were 
transcribed, and the resulting RNA was complexed with the Rev 
peptide to prepare an RNP pool for the next round of selection. 
 
Figure 2. Nucleotide sequences obtained from the randomized region of 
RRENn of dopamine-binding RNP receptors after 12 rounds of in vitro 
selection (DL-RNP pool) with a low salt concentration buffer. The numbers 
in parentheses indicate the number of clone with the same nucleotide 
sequence. Consensus sequences were shown in bold. 
 
Figure 3. Nucleotide sequences obtained from the randomized region of 
RRENn of dopamine-binding RNP receptors after 14 rounds of in vitro 
selection (DH-RNP pool) with a high salt concentration buffer. The numbers 
in parentheses indicate the number of clone with the same nucleotide 
sequence. Consensus sequences were shown in bold. 
 
After 12 rounds of iterative selection and amplification at the 
150 mM NaCl condition, 29 RNA clones were sequenced to 
reveal 16 unique sequences (designated as DL-RNP pool), which 
were composed of 14 to 37 nucleotides derived from the 
randomized RNA region (Figure 2). Fourteen clones (DL02) 
among the 29 sequenced clones were identical, and contained a 
highly conserved consensus sequence 5 ′ -
CCUAUACUGACGU-3 ′ . Two other types of consensus 
sequences were also identified in clones that possessed 14 to 37 
nucleotides in the randomized region. Similarly, after 14 rounds 
of the selection in the condition containing 300 mM NaCl, 
analysis of the nucleotide sequences of 27 clones identified 21 
unique sequences (designated as a DH-RNP pool), which were 
composed of 21 to 38 nucleotides derived from the randomized 
region (Figure 3). DH05 and DH22 represented six and two 
identical clones, respectively, shared a consensus sequence 5′-
UGAAAU-3′. There is no homology between the nucleotide 
sequences deduced from the DL- and DH-RNP pools except that 
DH09 RNA (Figure 3) shows a partial similarity to DL02 RNA 
(figure 2). It turned out that each selection procedure at the 
different salt concentration provided unique substrate-binding 
RNA sequences, indicating that the specific dopamine binding by 
RNP is highly dependent on the salt concentration. Moreover, 
these consensus sequences of DL- and DH-pools showed no 




2.2. Dopamine-binding assay of DL- and DH-RNPs based 
fluorescent RNP sensors.  
To investigate the affinity and the selectivity of isolated RNP 
receptors for dopamine, fluorescent RNP sensors were 
constructed according to the previously reported method.
15, 19-22, 26
 
The Rev peptide modified at the N-terminal with 7-
methoxycoumarin-3-carboxylic acid (7mC-Rev) was complexed 
with DL02 RNA (DL02/7mC-Rev) and DH05 RNA 
(DH05/7mC-Rev), the most abundant clones in the DL- and DH-
RNP pool, respectively. The relative ratio of fluorescence 
intensity (I/I0) in the absence (I0) and the presence (I) of 
dopamine for the fluorescent RNP complex DL02/7mC-Rev at 
405 nm increased up to 2.2-fold (Figure 4a). A nonlinear 
regression analysis of the titration curve yielded an equilibrium 
dissociation constant (KD) of 14.9 µM for the binding complex of 
DL02/7mC-Rev and dopamine. Similarly, DH05/7mC-Rev 
showed a 1.5-fold enhancement of I/I0 in response to the 
increasing concentration of dopamine (Figure 4b). The standard 
binding isotherm obtained from the titration curve provided a KD 
value of 4.1 µM.  
The selectivity of DL02/7mC-Rev and DH05/7mC-Rev for 
dopamine against other catecholamine derivatives was also 
studied by the fluorescence titration (Figures 4a and 4b). The 
dissociation constants for the complexes of DL02/7mC-Rev and 
DH05/7mC-Rev with a variety of catecholamine derivatives were 
obtained from the fluorescence titration curves and were 
summarized in Table 1. The affinity of both RNPs to tyrosine and 
L-dopa was much lower than that to dopamine. However, both 
DL02/7mC-Rev and DH05/7mC-Rev failed to discriminate 
dopamine from norepinephrine. Deletion of the aminoethyl group 
(catechol) and removal of the 3-hydroxyl group of benzene ring 
(tyramine) or the catechol moiety (ethylamine) resulted in 
complete loss of binding for DL02/7mC-Rev. The observed 
selectivity of DL02/7mC-Rev indicates that the catechol moiety 
including both the 3- and 4-hydroxyl groups and the aminoethyl 
group of dopamine strongly contribute to the ligand binding of 
DL02/7mC-Rev. Judging from the low affinity of DL02/7mC-
Rev to L-dopa or tyrosine, it responded to selection pressure 
through tyrosine-resin elimination. Thermodynamically, the 
carboxyl group at the α-position of amino group was disfavored 
for the complex formation with DL02/7mC-Rev. The carboxyl 
group prevents conjugation between ligand and DL02/7mC-Rev. 
In contrast, DH05/7mC-Rev showed a lower sensitivity to the 3-
hydroxyl group of the catechol moiety for the ligand-binding 
complex formation because it showed much higher affinity to 
tyramine as compared to DL02/7mC-Rev. DH05/7mC-Rev also 
showed a higher selectivity against the carboxyl group at the α-
position of amino group.  
Taken together, the selection scheme including the negative 
selection using tyrosine-agarose resin permitted a facile 
preparation of dopamine-binding RNP with high selectivity for 
the substitution at the α-carbon of the amino group and that at the 
catechol moiety. DH05 RNP obtained by the selection in the 
presence of 300 mM NaCl showed higher affinity to dopamine 
than DL02 RNP obtained with 150 mM NaCl. DH05/7mC-Rev 
exhibited selectivity and affinity that are comparable to the 
previously reported RNA aptamers.
31 
However, the selectivity of 
these RNP for the substitution at the β-carbon of the aliphatic 
chain remains to be improved. 
 
Figure 4. Titration curves for the changes of relative fluorescence intensity 
(I/I0) for (a) DL02/7mC-Rev and (b) DH05/7mC-Rev with dopamine (filled 
black circles), norepinephrine (open red squares), L-tyrosine (open green 
triangles), or L-dopa (open blown diamonds). 
 
2.3. Modification of the in vitro selection scheme by including a 
counter-selection step.  
We next applied a new selection scheme to isolate RNP that 
would discriminate dopamine against norepinephrine. The DH-
RNP pool obtained after 15 rounds of in vitro selection in the 
presence of 300 mM NaCl was subsequently subjected to a 
counter-selection
33-34
 by using norepinephrine as a competitive 
ligand, which differed from dopamine in a single hydroxyl group 
at the β-position of aliphatic chain (Figure 1a). In the counter 
Table 1. Equilibrium dissociation constants KD (µM) of dopamine-binding RNP for complexes with catecholamine derivatives. 
ligand DL02 DH05 DHc25 DHc58 DHc65 
dopamine 14.9 ± 2.3 4.1 ± 1.4 60 ± 9.5 42 ± 6 3.2 ± 0.4 
L-tyrosine > 300 247 ± 33 > 300 > 300 > 300 
L-dopa 86.4 ± 3.0 161 ± 31 > 300 > 300 > 300 
norepinephrine 21.7 ± 3.5 6.2 ± 1.5 326 ± 28 92.4 ± 14 4.2 ± 0.4 
epinephrine 26.4 ± 4.0 14.2 ± 2.6 173 ± 28 99 ± 20 20.0 ± 6.0 
catechol > 300 > 300 > 300 235 ± 62 108 ± 13.2 
tyramine > 300 27 ± 5.5 > 300 >280 145 ± 19.7 
ethylamine > 300 > 300 > 300 >300 >300 
phenethylamine > 300 > 300 > 300 >300 >300 
 
selection step, RNPs were washed off the column with a binding 
buffer containing norepinephrine (1 mM). The resin-bound 
RNPs were then specifically eluted by using a buffer containing 
5 mM dopamine. After additional 8 cycles of selection including 
the counter selection step, more convergent sequences were 
obtained as shown in Figure 5, designated as a DHc-RNP pool. 
It is noteworthy to mention that the isolated 14 clones were 
unique to the DHc-RNP pool and the consensus sequences 5'-
AGCAU---GCU--UA-3' found in the DHc-RNP pool was 
completely different from that of the starting DH-RNP pool.  
 
 
Figure 5. Nucleotide sequences obtained from the randomized region of 
RRENn of dopamine-binding RNP receptors isolated from the additional 8 
rounds of counter selection using norepinephrine for DH RNA pool. The 
numbers in parentheses indicate the number of clone with the same 
nucleotide sequence. Consensus sequences were shown in bold. 
 
 
Figure 6. Changes in the relative fluorescent intensity (I/I0) for the 
complexes of DHc RNAs and 7mC-Rev in the absence or presence of 
various concentrations (10 μM, 100 μM, 1 mM) of dopamine were evaluated 
at 390 nm. 
Each RNP from the DHc-RNP pool was subjected to a simple 
screening for its dopamine-binding by measuring I/I0 of 
fluorescent DHc-RNPs, which were formed by the complex 
formation of RNA in the DHc pool with 7mC-Rev, in the 
absence or presence of various concentrations of dopamine (10 
μM, 100 μM, 1 mM) and were summarized in Figure 6. This 
simple functional evaluation indicated that changes in the 
fluorescence signal are significant for the 7mC-Rev complexes 
of DHc25, DHc27, DHc43, DHc58 and DHc65. Comparison of 
I/I0 values at three different dopamine concentrations (10 μM, 
100 μM, 1 mM) suggests that DHc25, DHc42, DHc58 and 
DHc65 show high affinity to dopamine. Among the fluorescent 
DHc-RNPs, the dominant clone DHc25/7mC-Rev and minor 
clones DHc58/7mC-Rev and DHc65/7mC-Rev were selected for 
further analyses of their recognition mode of catecholamines. 
Titration of changes of the fluorescence intensities for 
DHc25/7mC-Rev with dopamine gave a KD of 60 μM for the 
complex. The KD value for the binding complex of 
norepinephrine was 326 μM. Comparison of the binding affinity 
of DHc25/7mC-Rev to other catecholamine derivatives (Table 
1) revealed that DHc25/7mC-Rev, the dominant RNP in the 
DHc pool, had a high selectivity to the aminoethyl chain of 
dopamine, norepinephrine and epinephrine, and showed no 
detectable binding affinity to catechol, tyramine, ethylamine or 
phenylethylamine. Tyrosine and L-dopa were not effective 
substrates for DHc25/7mC-Rev. DHc58/7mC-Rev also showed 
selective binding to dopamine, but not as specific as 
DHc25/7mC-Rev. The dopamine complex of DHc58/7mC-Rev 
was formed with KD of 42 μM, while its complexes of 
norepinephrine and epinephrine were formed with KD of 92 μM 
and 99 μM, respectively. Both DHc25/7mC-Rev and 
DHc58/7mC-Rev show binding characteristics that are different 
from DL02/7mC-Rev and DH05/7mC-Rev obtained from the 
early generation of the in vitro selection. On the other hand, the 
minor DHc65/7mC-Rev bounds catecholamines in the similar 
manner as DH05/7mC-Rev obtained from the parent DH-RNP 
pool. DHc65/7mC-Rev formed stable binding complexes of 
dopamine and norepinephrine with KD values of 3.2 and 4.2 µM, 
respectively. Both DHc25/7mC-Rev and DHc58/7mC-Rev 
exhibited improved binding selectivity for dopamine with the 
loss of binding affinity. The competitive binding condition 
reduced the population of RNP species that accommodate the 
hydroxyl group at the -position of the aliphatic chain of 
norepinephrine. 
 
Figure 7. Saturation curves for the fluorescence emission intensity of (a) 
DHc25/7mC-Rev, (b) DHc58/7mC-Rev and (c) DHc65/7mC-Rev by 
titration with dopamine (filled black circles), norepinephrine (open red 
squares), L-tyrosine (open green triangles), or epinephrine (open blue 
diamonds). 
 
2.4. Determination of thermodynamic parameters for the 
binding complexes of DHc RNPs and catecholamines.  
Possible secondary structures of the RNA subunits of 
selected RNP were obtained by using mfold v3.0 algorithm,
35-37
 
and shown in Figure S1. The overall secondary structures were 
calculated to maintain the secondary structure of the RRE 
sequence reported previously 
17
. Both DHc25 and DHc58 RNPs 
are expected to form AU bulge and UUAA loop structures 
(Figures S1a and S1b). These structures would provide similar 
binding characteristics DHc25 and DHc58 RNPs on the 
catecholamine recognition. The secondary structure of DHc65 
RNP, the minor RNP in the DHc-RNP pool, is different from 
that of DHc25 or DHc58 RNP. In addition, the secondary 
structures suggested for DHc25, DHc58 and DHc65 RNP are 




We next investigated thermodynamic parameters for the 
binding complexes of dopamine, norepinephrine and 
epinephrine with DHc25/7mC-Rev, DHc58/7mC-Rev and 
DHc65/7mC-Rev. The KD values of these complexes were 
obtained at 4, 10, 15, 20 and 25 °C, and were shown as the van’t 
Hoff plot (Figure S3).
38-40
 The data are fitted to the first order 
function of van't Hoff equation.
41
 Thermodynamic parameters 
obtained from the van't Hoff analysis of the binding constants 
for DHc25/7mC-Rev, DHc58/7mC-Rev and DHc65/7mC-Rev 
are summarized in Table 2. 
DHc25/7mC-Rev formed a dopamine-binding complex with 
enthalpy changes (H) of –17.5 kcal mol
-1
 and unfavorable 
entropy changes (-TS) of 12.2 kcal mol
-1
 at 4 °C. Binding of 
norepinephrine to DHc25/7mC-Rev was due to H of –13.5 kcal 
mol
-1
 and -TS of 9.0 kcal mol
-1
. Formation of a binding 
complex of DHc25/7mC-Rev and epinephrine associated with 
H of –14.8 kcal mol
-1
 and -TS of 10.0 kcal mol
-1 
(Table 2). 
Formation of the binding complex of DH25/7mC-Rev and 
catecholamine reveals that the favorable enthalpy changes for 
the binding of catecholamine are always offset by large 
unfavorable entropy changes. DHc58/7mC-Rev formed more 
energetically stable complexes with dopamine as compared to 
DHc25/7mC-Rev. Though the enthalpy changes for the 
dopamine complex formation of DHc58/7mC-Rev is larger than 
DHc25/7mC-Rev, it associates with larger unfavorable entropy 
changes (Table 2). Binding of catecholamines exhibited the 
enthalpy-entropy compensation phenomena for both 
DHc25/7mC-Rev and DHc58/7mC-Rev.
42
 Interactions between 
the 4-hydroxyl group substituted aromatic ring of catecholamine 
with DHc25/7mC-Rev and DHc58/7mC-Rev are more critical 
than that between the aliphatic chain of dopamine, 
norepinephrine or epinephrine. Presence of the hydroxyl group 
at the aliphatic chain of norepinephrine reduced the enthalpy 
changes for the complex formation with DHc25/7mC-Rev and 
DHc58/7mC-Rev. The methyl group at the terminal amino 
group of epinephrine contributed to further reduction of the 
binding affinity of epinephrine. Because DHc25/7mC-Rev and 
DHc58/7mC-Rev reveal quite similar contributions of both 
enthalpy and entropy changes for the dopamine-binding 
complex formation, the AU bulge and the UUAA loop (Figures 
S1a and S1b) that are common for both RNP would form the 
binding-pocket of these RNPs. The dopamine-binding complex 
of DHc58/7mC-Rev exhibited a slightly higher stability than 
that of DHc25/7mC-Rev, which likely results from a 
stabilization of the putative binding site by the longer stem 
region adjacent to the loop. However, DHc25/7mC-Rev, the 
dominant RNP in the DHc-RNP pool, showed higher selectivity 
over norepinephrine than DHc58/7mC-Rev. 
The minor RNP in the DHc-RNP pool, DHc65/7mC-Rev, 
showed a high affinity to dopamine but almost no specificity to 
norepinephrine and epinephrine. Isolation of DHc65 RNP 
witnesses a process of functional convergence of RNP during 
the selection scheme in the presence of the competitor, though 
the RNA sequence of DHc65 RNP does not share the consensus 
sequence found in the DH-RNP pool. DHc65 RNP displayed 
significantly different binding characteristics as compared to the 
other RNP from the DHc-pool, such as DHc25 and DHc58 RNP. 
Complex formation of DHc65/7mC-Rev with dopamine, 
norepinephrine or epinephrine revealed quite similar 
thermodynamic parameters. Both the enthalpy and entropy 
changes for the dopamine binding of DHc65 RNP are much 
larger than that of DHc25 or DHc58 RNP at 4°C, (Table 1). 
Though DHc65/7mC-Rev showed similar binding affinities to 
dopamine, norepinephrine and epinephrine, it prominently 
recognized both the 3- and 4-hydroxyl groups of catechol (Table 
Table 2 Thermodynamic parameters of dopamine, norepinephrine and epinephrine binding to DHc25 RNP, DHc58 RNP, and DHc65 RNP at 4 °C. 
DHcRNA/7mC- Rev Catecholamine H (kcal mol-1) –TS (kcal mol-1) G 4 °C (kcal mol
-1) 
DHc25/7mC Dopamine –17.5±0.5 12.2±0.4 –5.30±0.1 
 Norepinephrine –13.5±0.4 9.0±0.4 –4.49±0.0 
 Epinephrine –14.8±0.1 10.0±0.1 –4.81±0.0 
DHc58/7mC Dopamine –20.5±0.0 14.7±0.1 –5.75±0.0 
 Norepinephrine –16.9±0.2 11.8±0.2 –5.05±0.0 
 Epinephrine –14.8±0.0 9.6±0.0 –5.22±0.0 
DHc65/7mC Dopamine –24.9±0.2 17.9±0.3 –7.03±0.1 
 Norepinephrine –24.8±0.1 17.9±0.1 –6.91±0.1 
 Epinephrine –23.5±0.2 17.0±0.2 –6.51±0.1 
  
1). The observed large negative entropy changes associated with 
the formation of dopamine, norepinephrine and epinephrine 
complexes are quite similar each other, indicating that tertiary 
structural rearrangements for the formation of the complexes of 
DHc65/7mC-Rev with dopamine, norepinephrine and 
epinephrine take place in the similar degree. Although the 
number of nucleotides utilized for the ligand binding is similar 
for DHc65 RNP (22 nt) and DHc25 RNP (20 nt), DHc65 RNP 
forms the most stable dopamine-RNP complex studied here. The 
fact that DHc65 RNP shows a different recognition pattern from 
that of DHc25 RNP likely correlates to the difference in the 
secondary structures for these RNPs (Figure S1). 
 
2.5. Circular dichroismic measurements of the dopamine-
binding RNPs.  
Solution structures of DHc RNP in absence or presence of 
dopamine were studied by circular dichroism (CD) 
measurements
43
 to understand a possible correlation between the 
structures of RNP and their ligand-binding complexes. The CD 
spectra of DHc25 RNA, DHc25/7mC-Rev, and a complex of 
DHc25/7mC-Rev and dopamine are shown in Figure 8a. The 
DHc25 RNA had a strong positive band near 265nm and a 
negative peak near 240 nm,
44 
the characteristic feature of A-form 
RNA. The CD spectra of DHc25/7mC-Rev brought slight 
reduction in the molar ellipticity at 265nm and a larger negative 
band at 220 nm, which was induced by the conformational 
transition of the 7mC-Rev peptide from a random to an α-helical 
structure upon binding to the RRE sequence. The CD spectrum 
of DHc25/7mC-Rev in the presence of 1 mM dopamine was 
almost identical to that of DHc25/7mc-Rev. Binding of 
dopamine to DHc25/7mC-Rev caused little or no change in the 
molar ellipticity at 265nm. These results indicated that dopamine 
binds to a rather pre-organized binding site in DHc25 RNP. 
DHc58 RNP revealed almost no conformational change upon 
the dopamine binding. Although DHc25 RNP discriminate 
dopamine against norepinephrine, both the dopamine and 
norepinephrine complexes of DHc25 RNP revealed quite similar 
CD spectra (Figures S3 and S4). This was also the case for 
DHc58 RNP. 
In contrast, DHc65 RNP revealed a large conformational 
change upon its dopamine-binding complex formation (Figure 
8c). DHc65 RNA is also in the A-form structure and the 
formation of DHc65/7mC-Rev also induced the negative CD 
bands around 220 nm, assignable for the α-helix formation. 
Upon formation of a complex of DHc65/7mC-Rev and 
dopamine, a negative band was appeared at 290 nm and the 
positive band at 260 nm was increased. The result indicates that 
DHc65 RNP binds to dopamine by the induced-fit mechanism. 
3. Discussion  
The in vitro selection scheme including the negative selection 
step with tyrosine successfully reduced the population of RNP 
that showed affinity to tyrosine and L-dopa, the catecholamine 
derivatives with the carboxyl group. The high salt conditions 
applied in the selection step would reduce the interaction 
between the positively charged terminal amino group of 
dopamine and the negatively charged phosphate groups of RNP. 
In such conditions, it is expected that the complex formation of 
dopamine and RNP is dominantly governed by the interaction of 
the catechol group and the aliphatic side chain with RNP. This 
was born out in the present selection scheme. The in vitro 
selection with dopamine-bound resin at the high salt condition 
afforded DH05/7mC-Rev that formed a more stable dopamine-
binding complex than DL02/7mC-Rev, which was obtained by 
in vitro selection in the low salt condition. The fluorescent RNP 
sensor with the high affinity to dopamine DH05/7mC-Rev 
showed lower selectivity to tyramine than DL02/7mC-Rev 
obtained from in vitro selection at the low salt condition. Thus, 
application of the high salt selection scheme that is expected to 
reduce the nonspecific ligand binding governed by the charge 
interaction does not always afford RNP with a higher ligand 
selectivity. On the other hand, the in vitro selection scheme 
including the counter selection step from the DHc RNP pool, 
where norepinephrine was utilized as the competitive ligand, 
resulted in isolation of RNPs that showed selectivity to 
dopamine over norepinephrine. The dominant RNP in the DHc-
RNP pool, DHc25/7mC-Rev, showed  lower binding affinity but 
the higher selectivity to dopamine than DH05/7mC-Rev 
obtained from the parent DH-RNP pool. The obtained 
thermodynamic data revealed that our selection scheme against 
the undesired ligand attributed discrimination in the interaction 
of RNP with dopamine, norepinephrine and epinephrine, while 
the selection scheme to enhance the selectivity of RNP did not 




Figure 8. The CD spectra of (a) DHc25, (b) DHc58 and (c) 
DHc65. RNA only (red line), RNP only (blue line), and RNP 
with dopamine (green line) spectra were shown, respectively.  
 
CD spectral and thermodynamic data for the ligand-binding 
complexes of DHc25/7mC-Rev and DHc58/7mC-Rev are 
consistent with the pre-organized type of ligand-binding 
mechanism. The thermodynamic data indicates that the catechol 
ring is the critical recognition site for almost all the RNP 
selected and that the steric interference at the aliphatic chain is 
prone to lower the ligand-binding affinity for DHc25/7mC-Rev. 
DHc65/7mC-Rev forms catecholamine-binding complexes 
through the induced-fit mechanism, in which the equilibrium for 
the complex formation is often governed by faster kon and koff 
than the ligand-binding equilibrium of the pre-organized binding 
pocket.
45-46 
In order for the selection pressure to reach the 
affinity maturation, RNPs with the pre-organized binding pocket 
have to be washed off from the bound-resin with a large excess 
buffer or a longer incubation time to obtain RNPs that form 
ligand-binding complexes governed by slower kinetics.
47-49
 A 
selection pressure to emphasize the difference in kinetic 
behaviors of RNPs in the pool would be an alternative approach 
to obtain RNP with the high affinity and selectivity. 
 
4. Conclusions 
By applying the conditional selection scheme, we have 
obtained dopamine-binding RNPs with various binding 
characteristics and developed fluorescent RNP sensors for 
dopamine that show moderate selectivity against norepinephrine, 
and high selectivity over other catechol amines, such as 
epinephrine, L-dopa and tyrosine. The ligand-binding pockets 
are pre-organized for DHc25 and DHc58 RNP that showed 
similar recognition mode and binding mechanisms to dopamine. 
DHc25 and DHc58 RNP show higher selectivity against 
norepinephrine and epinephrine than DHc65 RNP, which forms 
a dopamine complex by the induced-fit mechanism. A selection 
scheme including a counter selection step by using a competitor 
norepinephrine afforded dopamine-binding RNPs with expected 
specificity. Based on the investigation of the thermodynamic 
parameters of the catecholamine-RNP complexes, the binding 
processes of catecholamines to RNP are all driven by enthalpy 
changes and exhibit the enthalpy-entropy compensation 
phenomena. Further refinements of the selection scheme, such 
as the kinetic control for the selection step, would realize in vitro 
selection of RNP with enhanced affinity and selectivity. 
 
5. Materials and Methods  
Dopamine immobilized agarose resin was purchased from 
ICN. L-Tyrosine immobilized on cross-linked 4% beaded 
agarose, L-dopa, norepinephrine, epinephrine, phenytylamine 
and tyrosine were purchased from Sigma-Aldrich. Catechol was 
purchased from Wako Chemicals. Tyramine was purchased 
from Tokyokasei. Klenow DNA polymerase, restriction enzyme 
(BamHI and EcoRI) and T4 polynucleotide kinase were 
purchased from New England Biolab. Gel electrophoresis grade 
acrylamide and bisacrylamide were obtained from Wako 
Chemicals. Rev peptide modified with acetic acid (Ac-Rev) and 
7-methoxycoumarin-3-carboxylic acid (7mC-Rev) were 
synthesized as described previously.
15, 19
 
5.1. Nucleic Acid Preparations.  
The nucleic acids used in this study were prepared according 
to the procedure previously reported.
22, 26
 Concentrations of 
RNA were determined by UV spectroscopy. 
5.2. In vitro selection of dopamine-binding RNP.  
The RRENn RNA library was prepared as previously 
reported 
19
 in the low salt buffer (100 μL) [50 mM Tris-HCl (pH 
7.6), 150 mM NaCl, 0.005 % Tween 20, 0.02 % ascorbic acid] 
or in the high salt buffer (100 μL) [50 mM Tris-HCl (pH 7.6), 
300 mM NaCl, 0.005 % Tween 20, 0.02 % ascorbic acid] by 
using 2 µM RNA and 3 µM Ac-Rev. Firstly, the negative 
selection step was carried out by using tyrosine-agarose resin (2 
mM). RNP was incubated with the tyrosine-immobilized 
agarose resin for 30 min on ice. The RNP-bound tyrosine-
agarose resin was washed three times with 300 μl of the low salt 
buffer. The flow-through fraction was subjected to the 
incubation with the dopamine- agarose resin (6 µM) in the low 
salt buffer. The RNP-bound resin was washed three times with 
300 μl of the low salt buffer. RNP bound to the resin was eluted 
with the low salt buffer containing 5 mM dopamine (150 μL) for 
two times. RNA of the recovered RNP was precipitated with 
ethanol and resuspended in TE buffer (50 µL). After reverse 
transcription with AMV(Avian Myeloblastosis Virus) reverse 
transcriptase (Promega) of the selected RNA using the 3’-DNA 
primer used in PCR amplification and successive PCR 
amplification (RT-PCR) using the 5’- and 3’-DNA primer, DNA 
templates were transcribed and the resulting RNAs were 
subjected to the next round of selection. After 12 rounds of low 
salt buffer selection, collected RNP pool was designated as the 
DL-RNP pool. In vitro selection in the high salt buffer was 
carried out in the similar manner for 14 rounds of selection to 
give the DH-RNP pool.  
5.3. Counter selection of dopamine binding ribonucleopeptide 
with presence of norepinephrine (RNA/Rev).  
The DH-RNP pool obtained from the high salt condition was 
subjected to another 8 rounds of selection by using an 
equilibrium binding buffer (100 μL) containing 50 mM Tris-HCl 
(pH 7.6), 300 mM NaCl, 0.005% Tween 20, 0.02% ascorbic 
acid, 1 mM norepinephrine and the RRENn RNP library (2 μM 
RNA and 3 μM Ac-Rev). RNP and the dopamine-immobilized 
agarose resin (6 μM) were incubated on ice for 30 min. The 
resin was washed three times with a buffer (300 μL) containing 
50 mM Tris-HCl (pH 7.6), 300 mM NaCl and 5 mM MgCl2. The 
resin-bound RNPs were eluted twice by the high salt buffer 
containing 5 mM dopamine. RNA of the recovered RNP was 
precipitated with ethanol and resuspended in TE buffer (50 µL). 
After reverse transcription with AMV reverse transcriptase 
(Promega) of the selected RNA using the 3’-DNA primer used 
in PCR amplification and successive PCR amplification (RT-
PCR) using the 5’- and 3’-DNA primer, DNA templates were 
transcribed and the resulting RNAs were subjected to the next 
round of selection. 
5.4. Sequencing Analysis of Selected RNA.  
Selected RNA pools were converted to DNA and PCR-
amplified to introduce BamHI and EcoRI restriction sites by 
using primers 5’-GCGGGATCCTTTCGGCCTGTACCGTCA-
3’ and 5’ CGGAATTCTAATACGACTCACTATAGG-3’. After 
enzymatic digestions, DNAs were cloned into the pUC 19 vector 
using Ligation Kit ver 2 (TaKaRa) and sequenced using a 
BigDye Terminator Cycle Sequencing Kit (Applied Biosystems) 
with a model 377 DNA sequencer (Applied Biosystems) 
5.5. Fluorescence measurements on the microplate.  
The 96-well fluorescence measurements were performed on a 
Wallac ARVOsx 1420 multilabel counter. The binding assay 
was evaluated by using the following conditions: 1 μM RNA 
and 1 μM 7mC-Rev in 50 mM Tris–HCl (pH 7.6), 5 mM MgCl2, 
0.005% Tween 20 and 0.02% ascorbic acid with 150 mM NaCl 
(DL-RNP) or with 300 mM NaCl (DH or DHc-RNP). Well-
mixed samples with different concentration of the ligands 
bearing catecholamine-related functional groups were incubated 
at 4 °C for 20 minutes, then emission spectra were measured 
(λex=355 nm, λem=390 nm). 
 
Fobs = A(([RNP]T + [substrate]T+KD) - (([RNP]T+[substrate]T +KD)
2 –  
        4[RNP]T[substrate]T)
1⁄2) ⁄ 2[RNP]T 
 
where A is the increase in fluorescence at saturating substrate 
concentrations (Fmax — Fmin), KD is the equilibrium dissociation 
constant, and [RNP]T and [substrate]T are the total 
concentrations of RNP and the substrate, respectively. 
5.6. RNA secondary structure prediction.  
Prediction of the secondary structure of DHc25 RNA, DHc 
58 RNA and DHc 65 RNA by using Mfold v3.0 algorithm 
(offered at http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-
bin/rna-form1.cgi.). Folding was done at 37°C with 1 M NaCl, 





5.7. Thermodynamic parameter of the RNP-ligand binding 
complexes.  
RNP (0.5 μM RNA: 0.5 μM 7mC-Rev) samples in binding 
buffer 50 mM Tris–HCl (pH 7.6), 300 mM NaCl, 5 mM MgCl2, 
0.005% Tween 20, 0.02% ascorbic acid with different 
concentration of catecholamine were prepared. Samples after 
well-mixed were incubated at different temperature: 4, 10, 15, 
20 and 25 °C for 20 minutes. Fluorescent intensity of samples 
was measured (λex=355 nm, λem=390 nm) by using Hitachi 
F7000 fluorescent spectrophotometer.  
 





 were extracted. Consequently, the changes in Gibbs 
free energy were calculated by the following formula
50 
(T=298 
















     (2) 
5.8. Circular Dichroism Spectroscopy Measurements.  
Circular dichroism spectra were recorded on a Jasco J-725J 
spectropolarimeter (Jasco, Inc., Easton, MD) interfaced with a 
computer and equipped with a heating/cooling device and 
nitrogen purging facilities. The CD spectrum of 3 μM DHc RNA, 
and 3 μM DHc RNP (ratio of RNA: 7mC-Rev= 1:4) complex 
with dopamine [1 mM or 50 μM (DHc 65)], norepinephrine [1 
mM or 50 μM (DHc 65)] or epinephrine [1 mM or 50 μM (DHc 
65)] were measured in 50 mM Tris–HCl (pH 7.6), 300 mM 
NaCl, 5 mM MgCl2, 0.005% Tween 20, and 0.02% ascorbic acid 
at 4 °C. The data were gathered at the average of 10 time scans 
(scanning rate of 100 nm/min) from 320 nm to 190 nm. The data 
were collected in units of millidegrees versus wavelength.   
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Table S1. Thermodynamic parameters of dopamine, norepinephrine and epinephrine binding 












Figure S1. Possible secondary structures of (a) DHc25 RNA, (b) DHc58 RNA and (c) DHc65 








Dopamine -11.1±2.3 4.7±2.3 -6.4±0.1 
Norepinephrine -9.9±0.4 3.8±0.3 -6.1±0.1 
Epinephrine -8.5±1.0 2.5±1.0 -6.0±0.1 
 
 
Figure S2. Saturation curves for the fluorescence emission intensity of (a) DL02/7mC-Rev, 
(b) DH05/7mC-Rev, (c) DHc25/7mC-Rev, (d) DHc58/7mC-Rev and (e) DHc65/7mC-Rev to 
dopamine (filled black circles), norepinephrine (open red circles), epinephrine (golden open 
reverse triangle), L-dopa (brown open diamonds), L-tyrosine (green open triangles), catechol 
(light blue open squares), tyramine (blue open diamonds), ethylamine (purple open reverse 
triangles), or phenyltylamine (red, open diamonds).  
  
Figure S3. The van't Hoff analysis of (a) DHc25/7mC-Rev, (b) DHc58/7mC-Rev and (c) 
DHc65/7mC-Rev complexes with dopamine (black close circles), norepinephrine (red open 
squares) or epinephrine (blue open diamonds). Dissociation constants for the RNP-ligand 
complexes were obtained by titrations of fluorescence intensity changes at 277, 283, 288, 293 







Figure S4. CD spectra of (a) DHc25, (b) DHc58 and (c) DHc65 with or without 
catecholamine. Spectra of RNP only (red line), RNP with dopamine (green line), 
norepinephrine (orange line) and epinephrine (purple line), respectively, were shown. 
 
